New data suggests that retatrutide, a dual-action medication, could represent a significant step in weight reduction . This therapy combines the actions of a GLP-1 analog and a GIP receptor , seemingly offering a more impact than existing solutions. Study research have demonstrated encouraging findings , including considerable declines in weight a